Virtual Medicinal Product (VMP) - Rivastigmine 2mg/ml oral solution
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rivastigmine 2mg/ml oral solution | Start Date 07-08-2012 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral solution
- Ontology Form/Route
- solution.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N06DA03
- BNF Codes
-
- BNF code 04110000
| Code | Start Date | End Date |
|---|---|---|
| 42041411000001107 | 07-07-2023 | |
| 408624008 | 09-08-2012 | 06-07-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Rivastigmine hydrogen tartrate | Based on Base Substance | Rivastigmine | 2 mg | 1 ml |
Name
Rivastigmine hydrogen tartrate
Basis of strength description
Based on Base Substance
BOSS
Rivastigmine
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
1
Parent Products
-
VTMRivastigmine
-
VMP(Current) Rivastigmine 2mg/ml oral solution
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 120 ml |